Anti-IgSF4 Antibody and Utilization of the Same

It is intended to clarify a molecule which is available as a target in treating or diagnosing cancer and utilize the molecule in the medical field or the research field. By treating IgSF4, which has been identified as a molecule specifically expressed in lung cancer cells, with an antibody, and ADCC...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: AKAHORI YASUSHI, KUROSAWA GENE, SUZUKI KAZUHIRO, UKAI YOSHINORI, MORISHITA KAZUHIRO, HAYASHI NOBUHIRO, MURAMATSU CHIHO, TAKASAKI AKIHIKO, TSUSTUMI SUSUMU, AZUMA MASACHIKA, MORITA MIWA, FUJIYAMA SARI, TAKAHASHI NOBUHIRO, SUMITOMO MARIKO, KUROSAWA YOSHIKAZU, IBA YOSHITAKA, SUGIOKA ATSUSHI, OGAWA KEIKO, MATSUDA KAZUKI
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:It is intended to clarify a molecule which is available as a target in treating or diagnosing cancer and utilize the molecule in the medical field or the research field. By treating IgSF4, which has been identified as a molecule specifically expressed in lung cancer cells, with an antibody, and ADCC activity is exerted. Based on this finding, an anti-IgSF4 antibody is provided as a means efficacious in treating cancer, etc.